Literature DB >> 1872835

NG-monomethyl-l-arginine (NMA) restores arterial blood pressure but reduces cardiac output in a canine model of endotoxic shock.

R E Klabunde1, R C Ritger.   

Abstract

Previous studies have suggested that NMA or similar inhibitors of nitric oxide synthesis from L-arginine reverses or prevents the hypotension associated with endotoxin administration. We wanted to determine if vascular and cardiac responses to NMA support the idea that inhibitors of nitric oxide synthesis might be useful in the treatment of septic shock. Pentobarbital-anesthetized beagle dogs were administered endotoxin for 2 hours at a dose of 250 ng/kg/min. This resulted in reductions in systemic vascular resistance (34% decrease) and mean arterial pressure (25% decrease). Administration of NMA (30 mg/kg, IV) caused large and sustained increases in mean arterial pressure and systemic vascular resistance, and a large decrease in cardiac output and femoral arterial blood flow. Although NMA restored arterial pressure, the large and sustained fall in cardiac output suggests that the cardiovascular action of NMA is detrimental to dogs treated with endotoxin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1872835     DOI: 10.1016/0006-291x(91)91010-a

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  Circulatory failure in septic shock. Nitric oxide: too much of a good thing?

Authors:  A J Brady; P A Poole-Wilson
Journal:  Br Heart J       Date:  1993-08

2.  Impaired vascular sensitivity to nitric oxide in the coronary microvasculature after endotoxaemia.

Authors:  R G Bogle; P G McLean; A Ahluwalia; P Vallance
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

3.  Short-term effects of methylene blue on hemodynamics and gas exchange in humans with septic shock.

Authors:  B Gachot; J P Bedos; B Veber; M Wolff; B Regnier
Journal:  Intensive Care Med       Date:  1995-12       Impact factor: 17.440

4.  Cardiac and regional haemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats.

Authors:  S M Gardiner; P A Kemp; J E March; T Bennett
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

5.  Effect of the platelet-activating factor antagonist, TCV-309, and the cyclo-oxygenase inhibitor, ibuprofen, on the haemodynamic changes in canine experimental endotoxic shock.

Authors:  S Yamanaka; H Iwao; T Yukimura; S Kim; K Miura
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

Review 6.  Role of nitric oxide in anaphylactic shock.

Authors:  H Mitsuhata; R Shimizu; M M Yokoyama
Journal:  J Clin Immunol       Date:  1995-11       Impact factor: 8.317

7.  Distribution of NOS isoforms in a porcine endotoxin shock model.

Authors:  Marie-Francoise Doursout; Takeshi Oguchi; Uwe M Fischer; YangYan Liang; Brice Chelly; Craig J Hartley; Jacques E Chelly
Journal:  Shock       Date:  2008-06       Impact factor: 3.454

8.  Iron chelates bind nitric oxide and decrease mortality in an experimental model of septic shock.

Authors:  W M Kazmierski; G Wolberg; J G Wilson; S R Smith; D S Williams; H H Thorp; L Molina
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

9.  Effects of nitric oxide synthase inhibition combined with nitric oxide inhalation in a porcine model of endotoxin shock.

Authors:  P Klemm; C Thiemermann; G Winklmaier; P A Martorana; R Henning
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

10.  The concomitant coronary vasodilator and positive inotropic actions of the nitroxyl donor Angeli's salt in the intact rat heart: contribution of soluble guanylyl cyclase-dependent and -independent mechanisms.

Authors:  Kai Yee Chin; Chengxue Qin; Nga Cao; Barbara K Kemp-Harper; Owen L Woodman; Rebecca H Ritchie
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.